Drug-glycosidation and drug development
Vijay K Kapoor1, Amanpreet Kaur
1G.H.G. Khalsa College of Pharmacy, Gurusar Sadhar (Ludhiana) 141104, India. vkkuips@yahoo.com
Mini Reviews in Medicinal Chemistry
|December 19, 2012
Summary
Synthetic drug glycosides offer a novel oral drug delivery method, targeting specific sites like the colon for enhanced efficacy and reduced side effects. These compounds also possess inherent biological activities, expanding their therapeutic potential.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Drug Delivery
Background:
- Achieving targeted drug delivery with minimal concentration and side effects is an ideal pharmaceutical goal.
- Drug targeting strategies aim to enhance therapeutic efficacy at the desired site of action.
Purpose of the Study:
- To review the approach of preparing synthetic drug glycosides for oral administration and targeted drug delivery.
- To explore the diverse biological activities of synthetic drug glycosides.
- To discuss synthetic methodologies for various glycoside types.
Main Methods:
- Preparation of synthetic glycosides of target drugs.
- Oral administration of drug glycosides.
- Enzymatic release of active drug in the colonic region.
- Review of synthetic approaches for O-, C-, N-, and S-glycosides.
Main Results:
- Synthetic drug glycosides can be orally administered and release active drugs enzymatically in the colon.
- Successful examples of this drug targeting approach have been documented.
- Synthetic drug glycosides exhibit various biological activities, including antineoplastic, antidiabetic, and anti-inflammatory properties.
Conclusions:
- Synthetic drug glycosides represent a promising strategy for targeted oral drug delivery.
- These compounds offer a dual benefit of drug targeting and intrinsic pharmacological activity.
- Further research into synthetic glycosides can unlock new therapeutic applications.
Related Concept Videos
Drug Metabolism: Phase II Reactions
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Phase II Reactions: Glucuronidation
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
Drug Biotransformation: Overview
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
Drug Biotransformation: Overview
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
Prodrugs
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...


